Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies

Chimeric antigen receptor (CAR) T cell therapy has revolutionized the therapeutic landscape of haematological malignancies. However, resistance and relapse remain prominent limitations, and they are related to the limited persistence and efficacy of CAR T cells, downregulation or loss of tumour anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Xinyi, Wang, Yazhuo, Zou, Zhengbang, Yang, Yufei, Wang, Xinyu, Xin, Xin, Tu, Sanfang, Li, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460961/
https://www.ncbi.nlm.nih.gov/pubmed/36091028
http://dx.doi.org/10.3389/fimmu.2022.954235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460961/
https://www.ncbi.nlm.nih.gov/pubmed/36091028
http://dx.doi.org/10.3389/fimmu.2022.954235

Ejemplares similares